NovaGold (NG) awards director Ethan Schutt 36,600 stock options

Rhea-AI Filing Summary

NovaGold Resources director Ethan Schutt received a new stock option grant. On 02/02/2026, he was awarded options to purchase 36,600 common shares at an exercise price of $8.73 per share. The options were granted for no cash payment to him and are held directly.

The options vest in three equal installments: one-third on 02/02/2027, one-third on 02/02/2028, and one-third on 02/02/2029, and expire on 02/01/2031 if not exercised.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schutt Ethan

(Last) (First) (Middle)

C/O NOVAGOLD RESOURCES INC.

201 SOUTH MAIN STREET, SUITE 400

(Street)

SALT LAKE CITY UT 84111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVAGOLD RESOURCES INC [ NG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.73	02/02/2026		A		36,600		(1)	02/01/2031	Common Shares	36,600	$0	36,600	D

Explanation of Responses:

1. The options vest as follows: 1/3 on 02/02/2027; 1/3 on 02/02/2028; and 1/3 on 02/02/2029.

Remarks:

	/s/ Ethan Schutt	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NovaGold (NG) report for Ethan Schutt?

NovaGold reported a grant of stock options to director Ethan Schutt. He received 36,600 options to buy common shares at $8.73 per share, granted at no cost, with the award dated 02/02/2026 and held as a direct ownership position.

What is the exercise price of the new NovaGold (NG) options granted to Ethan Schutt?

The new options granted to director Ethan Schutt have an exercise price of $8.73 per share. This means he can buy NovaGold common shares at $8.73 once vested, subject to the option terms and the specified vesting schedule through 2029.

How many NovaGold (NG) options does Ethan Schutt hold after this Form 4 filing?

After the reported transaction, director Ethan Schutt beneficially owns 36,600 stock options. These options give him the right to purchase 36,600 NovaGold common shares, subject to vesting dates and the final expiration date of 02/01/2031.

What is the vesting schedule for Ethan Schutt’s NovaGold (NG) stock options?

The options vest in three equal parts over three years. One-third vests on 02/02/2027, another third on 02/02/2028, and the final third on 02/02/2029, allowing progressive exercisability before the 02/01/2031 expiration date.

When do the newly granted NovaGold (NG) options to Ethan Schutt expire?

The stock options granted to director Ethan Schutt expire on 02/01/2031. If not exercised by that date, his right to purchase NovaGold common shares at the $8.73 exercise price under this specific grant will lapse.

Did Ethan Schutt pay anything for the NovaGold (NG) stock option grant?

The filing shows the price of the derivative security as $0, meaning the options were granted without a purchase payment. However, exercising them later would require paying the $8.73 per share exercise price for the underlying common shares.